Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pharnext, UHI to Evaluate Repurposed Drugs Against COVID-19 | Contract Pharma

What are you searching for?

Sign in
Breaking News

Pharnext, UHI to Evaluate Repurposed Drugs Against COVID-19

Aims to rapidly test several approved drugs as potential candidates for fighting COVID-19 using big data and artificial intelligence

By: Contract Pharma

Contract Pharma Staff

Pharnext, a clinical-stage biopharma company developing drug combinations based on big genomic data and artificial intelligence (AI), and the University Hospital Institute Méditerranée Infection, devoted to infectious and tropical diseases in France, have partnered to research potential drug candidates to fight COVID-19 virus.

The joint activities will focus on rapidly testing in vitro a number of already approved drugs that were previously identified by Pharnext as potential candidates for fighting COVID-19 using its PLEOTHERAPY AI platform. The testing will also include several high priority drug combination candidates against COVID-19, also using the PLEOTHERAPY AI platform. The testing will be performed by the UHI Méditerranée Infection in preclinical studies.

“We anticipate that with such an efficient and highly qualified team, important in vitro results will be forthcoming” said Daniel Cohen, M.D., Ph.D., Founder and President of the Scientific Advisory Board of Pharnext.

“We are all engaged in the same medical fight to treat COVID-19 patients as fast as possible to slow down the epidemic and prevent, treat severe forms of the disease” said Didier Raoult, M.D., Ph.D., Founder and Head of the UHI Méditerranée Infection.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics